High Implementation Adherence to Lenalidomide in Patients with Multiple Myeloma

被引：0
|
作者：
Leader, Avi [1 ,2 ]
Magen, Hila [1 ,3 ]
Amitai, Irina [1 ,4 ]
Pironet, Antoine [5 ]
Tousset, Eric [5 ]
Rozental, Alon [1 ,2 ]
De Geest, Sabina [6 ,7 ]
Vaxman, Iuliana [1 ,2 ]
Raanani, Pia [1 ,2 ]
Nagler, Arnon [1 ,8 ]
机构：
[1] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[2] Rabin Med Ctr, Davidoff Canc Ctr, Inst Hematol, Petah Tiqwa, Israel
[3] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Div Hematol, Ramat Gan, Israel
[5] AARDEX Grp, Liege, Belgium
[6] Univ Basel, Inst Nursing Sci, Dept Publ Hlth, Basel, Switzerland
[7] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Acad Ctr Nursing & Midwifery, Leuven, Belgium
[8] Chaim Sheba Med Ctr, Hematol & Bone Marrow Transplant Unit, Tel Hashomer, Israel
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8068 / 8069
页数：2
相关论文
共 50 条
  • [41] Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Kuo, Alyce M.
    Hassoun, Hani
    Shah, Urvi
    Gordon, Allison
    Hollmann, Travis J.
    Landau, Heather J.
    Lezcano, Cecilia
    Mailankody, Sham
    Tan, Carlyn C.
    Lesokhin, Alexander M.
    Markova, Alina
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2233 - 2237
  • [42] Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma
    Gao, Tiantao
    Liu, Xinghong
    Shen, Qi
    Luo, Zhu
    Feng, Ping
    Miao, Jia
    Zheng, Li
    Chen, Donglin
    Xiang, Jin
    CHINESE MEDICAL JOURNAL, 2022, 135 (02) : 250 - 252
  • [43] A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients
    Elsisi, Gihan Hamdy
    Carapinha, Joao L.
    Afify, Rania
    Abd Elmoty, Mohamed
    Khalaf, Mohamed
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (10) : 1168 - 1175
  • [44] Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Goldschmidt, Hartmut
    Alegre, Adrian
    Mark, Tomer
    Niesvizky, Ruben
    CANCER TREATMENT REVIEWS, 2012, 38 (08) : 1012 - 1019
  • [45] Diarrhea Incidence in Multiple Myeloma Patients Treated With Lenalidomide and Pomalidomide
    Montefusco, Vittorio
    Capecchi, Marco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E46 - E46
  • [46] Lenalidomide improves survival in previously treated patients with multiple myeloma
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (01): : 43 - 43
  • [47] THE SOCIETAL IMPACT OF LENALIDOMIDE IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA IN GERMANY
    Hofmann, S.
    Seddik, A.
    VALUE IN HEALTH, 2019, 22 : S478 - S478
  • [48] Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
    Ariana Berenson
    Suzie Vardanyan
    Michael David
    James Wang
    Nika Manik Harutyunyan
    Jillian Gottlieb
    Ran Halleluyan
    Tanya M. Spektor
    Kyle A. Udd
    Shahrooz Eshaghian
    Youram Nassir
    Benjamin Eades
    Regina Swift
    James R. Berenson
    Annals of Hematology, 2017, 96 : 449 - 459
  • [49] How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma
    de Arriba de la Fuente, Felipe
    Montes Gaisan, Carmen
    de la Rubia Comos, Javier
    CANCERS, 2023, 15 (01)
  • [50] DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE
    Capecchi, M.
    Corradini, P.
    Montefusco, V.
    HAEMATOLOGICA, 2016, 101 : 795 - 796
12345